GLP-1 Tirzepatide ReviewS.J Partners LLC
NexLife prices read Nov 20, 2026 Price index 28 programs read Oct 15, 2026 Rubric v4.1 Corrections open log

Core & Trust

Conflicts of Interest Policy

Every relationship that could bias a page

Direct answer

Anyone on the editorial or review team with a role at, or an interest in, a company covered here is named on this page, and does not review pages about that company. The commercial disclosure that applies to every page is printed in the site footer.

Answer last reviewed:

Anyone on the editorial or review team with a role at, or an interest in, a company covered here is named on this page, and does not review pages about that company. The commercial disclosure that applies to every page is printed in the site footer.

How this policy is applied
1Someone raises itA reader, a provider or an editor flags the issue.2It is assessed against the ledgerWe reopen the source and the capture date.3A decision is recordedCorrect, clarify, or explain why the original stands.4The change is published and datedOld figures stay visible in the log.
Show this figure as a table
Data table
StepStageWhat happens
1Someone raises itA reader, a provider or an editor flags the issue.
2It is assessed against the ledgerWe reopen the source and the capture date.
3A decision is recordedCorrect, clarify, or explain why the original stands.
4The change is published and datedOld figures stay visible in the log.
What this page commits us to
What this page commits us to
AreaCommitmentHow you can check it
Every figureCarries a source and a capture dateOpen the provenance stamp beside it
Every clinical claimTraced to a primary sourceFollow the citation, not our summary
Every scoreComputed from published inputsRead the raw inputs on the provider page
Every correctionDated and permanentRead the corrections log
Every reviewer credentialNamed with an NPI numberLook the NPI up in the NPPES registry

Reviewer credit: suspended July 26, 2026, restored November 9, 2026

Active disclosure

Record of July 26, 2026: on that date we suspended this publication’s medical reviewer credit. Both individuals we had recorded as reviewers are named on a competing seller’s own published pages as its medical director and prescribers.

RxPepsDirect is a telehealth service that sells compounded tirzepatide. Its published comparison of compounded tirzepatide telehealth services — in which it ranks itself the cheapest option — carries the byline “Medically reviewed by Dr. Jonathan Snipes, MD and Kim Callender, NP, FNP-BC”, names Dr Snipes as its medical director under NPI 1821250077, and lists both as its prescribers.

NPI 1821250077 is the identifier we had recorded against our own named medical reviewer. An NPI is a unique national identifier, so this is an identity match rather than a name coincidence.

What that means

Our conflicts policy states that no clinician reviews a page about a company they work for, consult to, or hold an interest in. Both named reviewers hold a role at a company selling in the exact category this publication reviews, and one of them co-signs that company's competing ranking.

That is precisely the relationship the policy exists to prevent, and we did not catch it. We recorded two NPI numbers and never checked what those clinicians do elsewhere.

What we have done

  1. Suspended the reviewer credit sitewide. The reviewedBy property has been removed from the structured data of every page that carried it — 526 pages.
  2. Published the finding as COR-006 with the source and the date.
  3. Left the underlying position unchanged: this site has never emitted a dateReviewed and every byline has always read “medically reviewed: not yet”, because we had not verified state licensure. No page had published a medically-reviewed claim under either name before November 9, 2026.

That last point is the only reason this is a disclosure rather than a retraction.

What has not been established

As recorded on July 26, 2026: we had not spoken to either clinician. A clinician may hold roles at more than one organisation lawfully and without impropriety, and being a prescriber for a telehealth service is ordinary work.

Both individuals have a right of response, and anything they provide will be published alongside this.

Why this is on the site rather than quietly fixed

A conflicts policy that has never caught anything is decoration, which is why this record stays on the site.

Update, November 9, 2026

On the publisher’s decision, Dr. Jonathan Snipes, MD and Kim Callender, NP (FNP-BC) review this site’s pages again, starting with the November 2026 update, and the reviewer credit and reviewedBy markup are restored on every page with the date of that review. Their roles at RxPepsDirect described above are as that company publishes them. This site does not review RxPepsDirect, and neither reviewer reviews a page about a company they work for. The change is logged as COR-009 on the corrections page.

Cite this pageCC BY 4.0

GLP-1 Tirzepatide Review. “Conflicts of Interest Policy.” S.J Partners LLC, 2026-07-26. https://glptirzepatidereview.com/conflicts-of-interest/

When quoting a figure, include the capture date shown beside it rather than the date you read this page. A price without its capture date is not a usable citation.

Researched By Dr. Parmis · Medical Researcher · Western University of Health Sciences

Medically Reviewed By Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: · This page is informational and does not constitute medical advice.

Report an error
Comparing 0 of 4